These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12809688)

  • 1. Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task.
    Buccafusco JJ; Terry AV; Goren T; Blaugrun E
    Neuroscience; 2003; 119(3):669-78. PubMed ID: 12809688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.
    Weinstock M; Bejar C; Wang RH; Poltyrev T; Gross A; Finberg JP; Youdim MB
    J Neural Transm Suppl; 2000; (60):157-69. PubMed ID: 11205137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].
    Youdim MB; Weinstock M
    Cell Mol Neurobiol; 2001 Dec; 21(6):555-73. PubMed ID: 12043833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor.
    Maruyama W; Weinstock M; Youdim MB; Nagai M; Naoi M
    Neurosci Lett; 2003 May; 341(3):233-6. PubMed ID: 12697291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.
    Weinstock M; Kirschbaum-Slager N; Lazarovici P; Bejar C; Youdim MB; Shoham S
    Ann N Y Acad Sci; 2001 Jun; 939():148-61. PubMed ID: 11462767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M; Poltyrev T; Bejar C; Youdim MB
    Psychopharmacology (Berl); 2002 Mar; 160(3):318-24. PubMed ID: 11889501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y; Weinstock M; Youdim MB
    J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid processing and signal transduction properties of antiparkinson-antialzheimer neuroprotective drugs rasagiline and TV3326.
    Youdim MB; Amit T; Bar-Am O; Weinstock M; Yogev-Falach M
    Ann N Y Acad Sci; 2003 May; 993():378-86; discussion 387-93. PubMed ID: 12853332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Curr Drug Targets; 2012 Apr; 13(4):483-94. PubMed ID: 22280345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline.
    Yogev-Falach M; Amit T; Bar-Am O; Weinstock M; Youdim MB
    FASEB J; 2002 Oct; 16(12):1674-6. PubMed ID: 12206996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys.
    Buccafusco JJ; Terry AV
    J Mol Neurosci; 2004; 24(1):85-91. PubMed ID: 15314255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Int Rev Neurobiol; 2011; 100():191-215. PubMed ID: 21971009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline.
    Youdim MB; Weinstock M
    Mech Ageing Dev; 2002 Apr; 123(8):1081-6. PubMed ID: 12044957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computer-assisted cognitive test battery for aged monkeys.
    Buccafusco JJ; Terry AV; Murdoch PB
    J Mol Neurosci; 2002; 19(1-2):179-85. PubMed ID: 12212778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil.
    Youdim MB; Amit T; Bar-Am O; Weinreb O; Yogev-Falach M
    Neurotox Res; 2006 Dec; 10(3-4):181-92. PubMed ID: 17197368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats.
    Bar-Am O; Weinreb O; Amit T; Youdim MB
    J Mol Neurosci; 2009 Feb; 37(2):135-45. PubMed ID: 18751929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing.
    Yogev-Falach M; Bar-Am O; Amit T; Weinreb O; Youdim MB
    FASEB J; 2006 Oct; 20(12):2177-9. PubMed ID: 16935943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys.
    Buccafusco JJ; Weiser T; Winter K; Klinder K; Terry AV
    Neuropharmacology; 2004 Jan; 46(1):10-22. PubMed ID: 14654093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys.
    Buccafusco JJ; Terry AV; Decker MW; Gopalakrishnan M
    Biochem Pharmacol; 2007 Oct; 74(8):1202-11. PubMed ID: 17706609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.